Nebivolol/valsartan

Nebivolol/valsartan

Combination of
Nebivolol	Beta blocker
Valsartan	Angiotensin II receptor blocker (ARB)
Clinical data
Trade names	Byvalson, Vyduo
AHFS/Drugs.com	Micromedex Detailed Consumer Information
License data	US  DailyMed:  Nebivolol hydrochloride and valsartan
Routes of administration	By mouth
ATC code	C09DX05 ( WHO )
Legal status
Legal status	US: ℞-only [1]
Identifiers
CAS Number	1268819-57-3
PubChem CID	73050811
KEGG	D11388

Nebivolol/valsartan, sold under the brand name Byvalson among others, is a medication used to treat hypertension. ^{[1] [2]}

It is available as a generic medication. ^[3]

References

1. "Byvalson (nebivolol and valsartan) tablets, for oral use Initial U.S. Approval: 2016". DailyMed. Archived from the original on 24 September 2022. Retrieved 23 September 2022.
2. Lamberton NH, Copenhaver AM (January 2018). "Nebivolol/Valsartan (Byvalson) for Hypertension". American Family Physician. 97 (2): 124–125. PMID   29365224. Archived from the original on 24 September 2022. Retrieved 24 September 2022.
3. "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.

Further reading

• Ishak J, Rael M, Punzi H, Gradman A, Anderson LM, Patel M, et al. (January 2018). "Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension". Journal of Clinical Hypertension. 20 (1): 143–149. doi: 10.1111/jch.13132 . PMC   5813198 . PMID   29105958.

External links

• "Nebivolol hydrochloride mixture with valsartan". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 24 September 2022.